Course curriculum

    1. Keynote Address: Future and Emerging Disease-Modifying Therapies Targeting BAFF and APRIL

    2. Welcome Address

    3. Clinical Endpoints for Glomerular Disease

    4. Surrogate Endpoints and Biomarkers for Glomerular Diseases

    5. Treatment Effect and Sample Size, Statistical Analysis Plan

    6. Trial Designs: Basket Trials, Umbrella Trials, Platform Trials, Pragmatic Trials

    7. Accelerated Approval, Full Approval, and The Regulatory Process

    8. Post-market Evaluations, Registries, and RWE Studies

    9. Why Trials Struggle to Recruit

    1. Keynote Address

    2. IgA Nephropathy

    3. Membranous Nephropathy

    4. Podocytopathies

    5. EMBARK Awareness - Closing the Gaps: Unmet Needs and Rising Opportunities for Community Education and Engagement

    1. Keynote Address: Rare Glomerular Disease Drug Development Insights and Challenges from Industry

    2. Lupus Nephritis

    3. Paraprotein Mediated Kidney Disease

    4. Glomerular Disease as a Subspecialty Roundtable

    5. GN Clinic and Centers of Excellence Roundtable

    6. Oral Poster Presentations

    7. Perspectives

    1. Keynote Address by Dr. Richard Glassock

    2. C3 Glomerulopathy

    3. Oral Poster Presentations

    4. ANCA/Anti-GBM Glomerulonephritis

    5. Lost in Translation - A Critical Appraisal of KDIGO Guidelines

About this course

  • Free
  • 26 lessons
  • 27 hours of video content

Discover your potential, starting today

Enroll today